13D·WATCH Activist + Insider Intelligence Live feed Blog About Pilot
SCHEDULE Filed 2025-02-04 Event 2025-02-03 SEC 0001373604-25-000005 →

BML Investment Partners, L.P. Aadi Bioscience, Inc. WHWK

Stake: 9.90% Shares: 2,435,000 CUSIP: 00032Q104 Class: Common stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

The Reporting Persons purchased the Common Stock reported hereunder for investment purposes, and such purchases were made in the Reporting Persons' ordinary course of business. As with their other investments, the Reporting Persons continuously evaluate the Issuer, including but not limited to its businesses, results of operations, and prospects. On February 3rd, legal counsel for the Reporting Persons sent a letter via certified mail to the Board of Directors of the Issuer. The letter is the Reporting Persons demand to inspect certain books and records of the Company (the "Demand") pursuant to 8 Del. C. 220 (Section 220) relating to Aadi's decision to pass up a favorable sale of the Company in favor of a dilutive, discounted, and conflicted financing agreement and the sale of its main asset, while preserving managements' employment and compensation. All of the shares of Common Stock reported herein as being beneficially owned by the Reporting Persons were acquired for investment purposes. Except as set forth herein, none of the Reporting Persons has any plans or proposals that related to or would result in any of the transactions described in Item 4 of Schedule 13D. The Reporting Persons reserve the right to acquire, or cause to be acquired, additional securities of the Issuer, to dispose of, or cause to be disposed, such securities at any time or to formulate other purposes, plans or proposals regarding the Issuer or any of its securities, to the extent deemed advisable in light of general investment and trading policies of the Reporting Persons, market conditions or other factors.

Cross-References

Insider Activity (last 365d)
1 transaction
0 buys · 1 sales · 0 awards/exercises
Issuer Cluster
6 13D/G filings on this issuer
5 other filings besides this one
Filer Track Record
2 filings by this filer
1 other filing in the data moat
Short Interest · settle 2026-03-31
DTC 3.88
693,909 shares short · -3.9% vs prior

Form 4 Insider Transactions · last 365d

DateInsiderRoleTypeSharesPriceValue
2026-04-13 BALL BRYAN officer Sale 26,389 $3.46 $91K

Other 13D/G Filings on Aadi Bioscience, Inc.

FiledFormFilerStakeShares
2025-03-06 SCHEDULE Desai Neil 4.90% 2,272,941 view →
2025-03-04 SCHEDULE Avoro Capital Advisors LLC 19.99% 11,914,961 view →
2025-02-24 SCHEDULE BML Investment Partners, L.P. 9.90% 2,435,000 view →
2025-01-24 SCHEDULE ACUTA CAPITAL PARTNERS, LLC 7.80% 1,921,297 view →
2018-07-02 SC ORBIMED ADVISORS LLC view →

Other Filings by BML Investment Partners, L.P.

FiledFormIssuerStakeShares
2025-02-24 SCHEDULE Aadi Bioscience, Inc. WHWK 9.90% 2,435,000 view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →